Application 065047
- Type
- ANDA
- Sponsor
- HIKMA FARMACEUTICA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFAZOLIN SODIUM | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | Yes |
| 002 | CEFAZOLIN SODIUM | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065047-001 | CEFAZOLIN SODIUM | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 |
| A065047-002 | CEFAZOLIN SODIUM | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A065047-001 | AP |
| A065047-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2001-09-18 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2001-09-18 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065047-001 | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A065047-002 | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2001-09-18 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A065047-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A065047-002 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A065047-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065047-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065047-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065047-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065047-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065047-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065047-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065047-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065047-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065047-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065047-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065047-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065047-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065047-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065047-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065047-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065047-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065047-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065047-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065047-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065047-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065047-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065047-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065047-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065047-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065047-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065047-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A065047-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065047-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065047-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A065047-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A065047-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065047-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A065047-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065047-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065047-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065047-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A065047-002 | AP | 1 | bb7c543d1eb4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefazolin | CEFAZOLIN | Hikma Pharmaceuticals USA Inc. | 26de1ce9-06a9-486f-b27d-2ac635f018d1 | 2026-05-14 | Warnings, Adverse reactions | 065047 ANDA065047 0143-9262 |
| Cefazolin | CEFAZOLIN | Civica, Inc. | 9ea55207-6d86-401e-b9b9-73c9534a233f | 2026-05-14 | Warnings, Adverse reactions | 065047 ANDA065047 72572-055 |
| Cefazolin | CEFAZOLIN | Hikma Pharmaceuticals USA Inc. | 1dc9de56-e259-4546-a1db-23119a8a088e | 2026-05-14 | Warnings, Adverse reactions | 065047 ANDA065047 0143-9923 0143-9924 |
| CEFAZOLIN | CEFAZOLIN | Henry Schein, Inc. | 197d5702-2c20-480e-8246-4d0d21f871be | 2025-10-27 | Warnings | 065047 ANDA065047 0404-9834 |
| CEFAZOLIN | CEFAZOLIN | Henry Schein Inc. | 922fb1a1-ad4c-4a12-8d5d-00fe13af18e8 | 2025-10-27 | Warnings, Adverse reactions | 065047 ANDA065047 0404-9835 |
| Cefazolin | CEFAZOLIN | A-S Medication Solutions | 8a772acc-726d-40e6-88ee-b6075cbf9b28 | 2023-06-23 | Warnings, Adverse reactions | 065047 ANDA065047 50090-4256 |
| Cefazolin | CEFAZOLIN | Medical Purchasing Solutions, LLC | 6673be13-4c74-70b9-e053-2a91aa0a211d | 2023-06-01 | Warnings, Adverse reactions | 065047 ANDA065047 71872-7027 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0143-9262 | Cefazolin | Cefazolin | West-Ward Pharmaceuticals Corp | ANDA | Current |
| 0143-9262 | Cefazolin | Cefazolin | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0143-9923 | Cefazolin | Cefazolin | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0143-9923 | Cefazolin | Cefazolin | West-Ward Pharmaceuticals Corp | ANDA | Current |
| 0143-9924 | Cefazolin | Cefazolin | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0143-9924 | Cefazolin | Cefazolin | West-Ward Pharmaceuticals Corp | ANDA | Current |
| 0404-9834 | CEFAZOLIN | cefazolin | Henry Schein, Inc. | ANDA | Current |
| 0404-9834 | CEFAZOLIN | cefazolin | Henry Schein, Inc. | ANDA | Current |
| 0404-9834 | CEFAZOLIN | cefazolin | Henry Schein, Inc. | ANDA | Current |
| 0404-9834 | CEFAZOLIN | cefazolin | Henry Schein, Inc. | ANDA | Current |
| 0404-9835 | CEFAZOLIN | cefazolin | Henry Schein Inc. | ANDA | Current |
| 0404-9835 | CEFAZOLIN | cefazolin | Henry Schein Inc. | ANDA | Current |
| 0404-9835 | CEFAZOLIN | cefazolin | Henry Schein Inc. | ANDA | Current |
| 50090-4256 | Cefazolin | Cefazolin | A-S Medication Solutions | ANDA | Current |
| 52584-923 | CEFAZOLIN | cefazolin | General Injectables & Vaccines, Inc. | ANDA | Current |
| 52584-923 | CEFAZOLIN | cefazolin | General Injectables & Vaccines, Inc. | ANDA | Current |
| 52584-923 | CEFAZOLIN | cefazolin | General Injectables & Vaccines, Inc. | ANDA | Current |
| 52584-924 | CEFAZOLIN | cefazolin | General Injectables and Vaccines, Inc. | ANDA | Current |
| 52584-924 | CEFAZOLIN | cefazolin | General Injectables and Vaccines, Inc. | ANDA | Current |
| 52584-924 | CEFAZOLIN | cefazolin | General Injectables and Vaccines, Inc. | ANDA | Current |
| 55154-7463 | Cefazolin | Cefazolin | Cardinal Health | ANDA | Current |
| 71872-7027 | Cefazolin | Cefazolin | Medical Purchasing Solutions, LLC | ANDA | Current |
| 71872-7027 | Cefazolin | Cefazolin | Medical Purchasing Solutions, LLC | ANDA | Current |
| 72572-055 | Cefazolin | Cefazolin | Civica, Inc. | ANDA | Current |